COMMON STOCK PURCHASE WARRANT bio-path holdings, inc.Common Stock Purchase Warrant • April 2nd, 2018 • Bio-Path Holdings Inc • Pharmaceutical preparations
Contract Type FiledApril 2nd, 2018 Company IndustryTHIS COMMON STOCK PURCHASE WARRANT (the “Warrant”), dated as of November 6, 2017, certifies that, for value received, Roth Capital Partners, LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May 6, 2018 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 3, 2022 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), up to 160,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).